Pilot/Feasibility Studies Program of the HCV Persistence Study Group (HPSG)

HCV 持久性研究小组 (HPSG) 试点/可行性研究计划

• 批准号: 8376123
• 负责人: RAYMOND T CHUNG
• 金额: $ 20.57万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-06-01 至 2014-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8376123
• 关键词: Appointment; Area; Award; Chronic; Collaborations; Communities; Complex; Development; Disease; Faculty; Failure; Feasibility Studies; Fostering; Funding; Funding Agency; General Hospitals; Goals; Grant; Growth; Hepatitis C; Hepatitis C virus; Immune; Infection; Institution; Journals; Laboratories; Lead; Massachusetts; Mission; Monitor; Participant; Peer Review; Postdoctoral Fellow; Publications; Reporting; Research; Research Personnel; Scientist; United States National Institutes of Health; Viral; Virus Diseases; Visit; design; gastrointestinal; innovation; member; novel; operation; pathogen; programs; symposium

The overall goal of the PFS is to stimulate innovative research relevant to mechanisms of viral persistence. This program is one mechanism through which this collaborative Study Group will facilitate the development of young investigators focused on areas relevant to the scientific mission of the HPSG and will encourage basic investigators to extend their studies into chronic viral infections, often in collaboration with members of the HPSG directly focused on these disorders. An important parallel goal is to foster the growth of young investigators, in the hope of increasing the number of workers studying these disorders. It should be emphasized that PFS awards are not designed to serve as "bridge funding" for investigators "between grants" or to support projects with pending support from outside funding agencies. It is anticipated that PFS recipients will lead to further, ongoing research funding by external peer-reviewed agencies as well as results warranting publication in peer-reviewed journals. Three general types of PFS applications will be considered for funding: TYPE I Those from young investigators without current or past independent NIH support establishing research programs relevant to the Aims of the HPSG. Applicants for this type of award generally hold an initial faculty appointment; senior post-doctoral fellows may also apply if there is a documented commitment by their department t a faculty appointment within the PFS support period TYPE II Those from established scientists not currently focused on chronic infection with Emerging Pathogens per se who will extend their studies to encompass issues of direct of indirect importance to understanding chronic viral infection TYPE III Those from investigators with novel projects distinctly removed from their established research program. All members of the participant HPSG institutions are eligible to receive funding through the PFS program. They are expected to attend HPSG seminars, interact with other center investigators and present their findings to the members of the HPSG in addition to formal reporting to the Executive Committee as described below. While the goals of the PFS program encompasses the three types of applications noted above, TYPE I proposals have highest priority. An investigator may not receive more than one PFS award during the HPSG grant period.

PFS的总体目标是刺激与病毒持久性机制相关的创新研究。